February 27, 2015 (v1)
Publication
No description
Uploaded on: March 27, 2023
-
-
September 10, 2024 (v1)Publication
Objectives: The course of progressive liver damage after achieving sustained virological response (SVR) with direct-acting antivirals (DAAs) remains undetermined. We aimed to determine risk factors associated with the development of liver-related events (LREs) after SVR, focusing on the utility of non-invasive markers. Methods: An...
Uploaded on: September 11, 2024 -
September 27, 2022 (v1)Publication
Introduction: patients with advanced chronic liver disease (CLD) may be at an increased risk of a severe course due to cirrhosis-associated immune dysfunction. The aim of this study was to determine the prevalence of CLD in COVID-19 patients and to analyze the course of the infection, compared with patients with non-liver disease. Materials and...
Uploaded on: March 24, 2023